Related Experiment Videos
Drug-induced linear immunoglobulin A disease
1Department of Dermatology, Bristol Royal Infirmary, Bristol, and Churchill Hospital, Oxford, United Kingdom.
Clinics in Dermatology
|October 1, 1993
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Doxycycline compared with prednisolone therapy for patients with bullous pemphigoid: cost-effectiveness analysis of the BLISTER trial.
The British journal of dermatology·2017
Updated evidence-based (S2e) European Dermatology Forum guideline on topical corticosteroids in pregnancy.
Journal of the European Academy of Dermatology and Venereology : JEADV·2017
Current practice in treatment approach for bullous pemphigoid: comparison between national surveys from the Netherlands and the UK.
Clinical and experimental dermatology·2016
Evidence-based (S3) Guideline on (anogenital) Lichen sclerosus.
Journal of the European Academy of Dermatology and Venereology : JEADV·2015
A randomized controlled trial to compare the safety and effectiveness of doxycycline (200 mg daily) with oral prednisolone (0.5 mg kg(-1) daily) for initial treatment of bullous pemphigoid: a protocol for the Bullous Pemphigoid Steroids and Tetracyclines (BLISTER) Trial.
The British journal of dermatology·2015
Sebaceous carcinoma in patients receiving long-term immunosuppresive treatment: case report and literature review.
Transplantation proceedings·2014
Art, Decadence, and Dermatology in 1920s Berlin: Three Portraits by Christian Schad.
Clinics in dermatology·2026
Art and the Heart. New Concepts in Heart Failure.
Clinics in dermatology·2026
Fast-tracking dermatologic care for "VIP" patients: ethical concerns and practical approaches.
Clinics in dermatology·2026
Ethics of suggesting image-guided superficial radiation therapy in the pathology report.
Clinics in dermatology·2026
Dabrafenib-Induced Cutaneous Eruptions in a Patient With Langerhans Cell Histiocytosis.
Case reports in dermatological medicine·2026
Type 1 diabetes mellitus induced by sintilimab: a case report and related case literature analysis.
Frontiers in endocrinology·2026
Lipocalin-2 Emerges as a Core Pathogenic Mediator and Biomarker in Autosomal Dominant Tubulointerstitial Kidney Disease-UMOD via Transcriptomic Profiling.
Kidney diseases (Basel, Switzerland)·2026
Targeting TKT-associated immunometabolic remodeling attenuates experimental lupus nephritis and NET-related inflammation.
Frontiers in cell and developmental biology·2026